Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study

被引:219
作者
Wei, L [1 ]
Wang, J [1 ]
Thompson, P [1 ]
Wong, S [1 ]
Struthers, AD [1 ]
MacDonald, TM [1 ]
机构
[1] Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Med Monitoring Unit, Dundee DD1 9SY, Scotland
关键词
D O I
10.1136/heart.88.3.229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate patients' adherence to statin treatment prescribed following their first myocardial infarction (MI) and to estimate the effect of adherence to statins on recurrence of MI and all cause mortality. Design: Cohort study using a record linkage database. Setting: Tayside, Scotland, UK. Patients: Patients who experienced their first MI between January 1990 and November 1995. Main outcome measures: Percentage of statin use and adherence to statins by patients after an MI and the relative risk of hospitalisation for recurrent MI. The effect of adherence on all cause mortality was also examined. The covariates used were age, sex, socioeconomic deprivation, serum cholesterol concentration, diabetes mellitus, cardiovascular drug use, and other hospitalisations. Results: Of 5590 patients who experienced an incident MI, 717 (12.8%) experienced at least one further MI. Only 7.7% of patients used statins after an MI during the study period. Compared with those not taking statins, those who had 80% or better adherence to statin treatment had an adjusted relative risk of recurrent MI of 0.19 (95% confidence interval (CI) 0.08 to 0.47) and all cause mortality of 0.47 (95% CI 0.22 to 0.99). There was no significant reduction in either end point for those who were less than 80% adherent to statins. Conclusions: Despite the infrequent use of statin during the study period, good adherence to statin. treatment was associated with lower risk of recurrent MI.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 22 条
  • [1] DISCONTINUATION OF ANTIHYPERLIPIDEMIC DRUGS - DO RATES REPORTED IN CLINICAL-TRIALS REFLECT RATES IN PRIMARY-CARE SETTINGS
    ANDRADE, SE
    WALKER, AM
    GOTTLIEB, LK
    HOLLENBERG, NK
    TESTA, MA
    SAPERIA, GM
    PLATT, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) : 1125 - 1131
  • [2] Persistence of use of lipid-lowering medications - A cross-national study
    Avorn, J
    Monette, J
    Lacour, A
    Bohn, RL
    Monane, M
    Mogun, H
    LeLorier, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1458 - 1462
  • [3] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS
    Downs, JR
    Clearfield, M
    Weis, S
    Whitney, E
    Shapiro, DR
    Beere, PA
    Langendorfer, A
    Stein, EA
    Kruyer, W
    Gotto, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20): : 1615 - 1622
  • [4] EVANS JMM, 2000, PHARMACOEPIDEM DR S, P361
  • [5] Fonarow GC, 2001, CIRCULATION, V103, P38
  • [6] Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
    Gottlieb, SS
    McCarter, RJ
    Vogel, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (08) : 489 - 497
  • [7] *INF STAT DIV, 2001, SCOTT HLTH SURV 2000, pC8
  • [8] The problem of compliance to cholesterol altering therapy
    Insull, W
    [J]. JOURNAL OF INTERNAL MEDICINE, 1997, 241 (04) : 317 - 325
  • [9] Effect of statins on risk of coronary disease - A meta-analysis of randomized controlled trials
    LaRosa, JC
    He, J
    Vupputuri, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24): : 2340 - 2346
  • [10] Enhancing drug compliance in lipid-lowering treatment
    LaRosa, JH
    LaRosa, JC
    [J]. ARCHIVES OF FAMILY MEDICINE, 2000, 9 (10) : 1169 - 1175